Effingo Technology Appoints Legal-Tech Trailblazer Nikki Mehrpoo, "The MedLegal Professor," as Chief Legal Innovation Strategist to Lead AI-Driven Med-Legal & Compliance Transformation
Effingo Technology Appoints Nikki Mehrpoo, 'The MedLegal Professor,' to Spearhead a Bold Leap in AI-Powered Compliance, Med-Legal Transformation, and Intelligent System Modernization, Uniting Law, Medicine, and Technology to Redefine the Future of Legal Innovation.
ORANGE, CALIFORNIA / ACCESS Newswire / April 21, 2025 / Effingo Technology ( www.effingotech.com ), the AI-powered automation leader revolutionizing documentation in the medical, legal, and insurance sectors, proudly announces the appointment of Nikki Mehrpoo, legal-tech pioneer and The MedLegal Professor ™ ( MedLegalProfessor.AI ), as its new Chief Legal Innovation Strategist.Effingo Technology & The MedLegal Professor Workers' Compensation AI Champions
Nikki's appointment marks a pivotal moment in Effingo's mission to solve the industry's toughest challenges. Her rare expertise across law, medicine, and technology positions her to lead the next era of med-legal innovation.
Industry Leader - 'Nikki is an empowering transformational leader,' said Jonathan Norzagaray, CEO of Effingo. 'Her unique blend of legal precision and strategic foresight will drive real ROI for our clients and accelerate our impact industry-wide.'
The Total Package - Nikki is California's only attorney certified as a legal specialist in both Workers' Compensation and Immigration Law. She's served as a judge, professor, expert witness, and AI + HI strategist, known nationally for shaping conversations around ethical and responsible AI and innovation on platforms like WorkersCompensation.com and WorkCompCollege.com. She advises across the spectrum, on AI adoption, integration and implementation, financial strategy, and executive leadership, bringing a legal mind, a C-suite lens, and a startup soul.
A Voice Rooted in Purpose - 'Over 30 years ago, as a young Persian woman in law school, the expectation was simple: get married and stay home,' said Nikki Mehrpoo. 'But I envisioned something more. This role is not just a career milestone-it's a personal victory for purpose, perseverance, and progress.'
From SME to Strategic Architect - Before this appointment, Nikki has been part of the Effingo team as a Subject Matter Expert and Legal Technology Advisor, helping shape Effingo's future. Her work directly tackled:
Leadership in EAMS Modernization - Among her many technology initiatives, Nikki continues to serve as a core Subject Matter Expert for organizations participating in the RFP bid process for California's EAMS Modernization Project, which aims to modernize technology systems handling over 8 million cases and 90 million documents.
Driving the Future of Legal-Tech - As Chief Legal Innovation Strategist, Nikki will lead Effingo's strategic roadmap with a focus on:
Effingo's proprietary E-AI engine scans thousands of pages, identifying redundant or irrelevant content with 99% accuracy, reducing review time from hours to seconds. There is a significant financial incentive to use Effingo, leading to millions of dollars in savings, faster claim turnarounds, and hundreds of hours saved.
About Effingo Technology - Effingo Technology ( www.effingotech.com ) delivers AI-powered, compliance-first automation that eliminates medical record duplicity and streamlines workflows for the legal-medical-insurance ecosystem. Its E-AI engine analyzes 100 to 1,000+ page files with unmatched accuracy, far surpassing human review or traditional OCR tools. Effingo's secure, HIPAA-compliant platform produces audit-ready reports, smart summaries, and real-time reference links, driving efficiency, reducing delays, and saving clients millions.
Contact InformationJonathan Norzagaray President & CEO of Effingo, LLC. and Physician's First Choice (562) 237-3562Nikki Mehrpoo, The MedLegal Professor Chief Legal Innovation Strategist (844) 466-7569
SOURCE: Effingo Technology
press release
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Associated Press
10 hours ago
- Associated Press
TMCI DEADLINE TUESDAY: ROSEN, LEADING TRIAL ATTORNEYS, Encourages Treace Medical Concepts, Inc. Investors to Secure Counsel Before Important June 10 Deadline in Securities Class Action
New York, New York--(Newsfile Corp. - June 7, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Treace Medical Concepts, Inc. (NASDAQ: TMCI) between May 8, 2023 and May 7, 2024, both dates inclusive (the 'Class Period'), of the important June 10, 2025 lead plaintiff deadline. SO WHAT: If you purchased Treace Medical securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO DO NEXT: To join the Treace Medical class action, go to or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than June 10, 2025. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers. DETAILS OF THE CASE: According to the lawsuit, during the Class Period, defendants made false and/or misleading statements and/or failed to disclose that: (1) competition impacted the demand for and utilization of its primary product, the Lapiplasty 3D Bunion Correction System (the 'Lapiplasty'); (2) as a result, Treace Medical's revenue declined and Treace Medical needed to accelerate its plans to offer a product that was an alternative to osteotomy (a surgical procedure that involves cutting and realigning a bone to improve its position or function); and (3) defendants' positive statements about Treace Medical's business, operations, and prospects were materially misleading and/or lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages. To join the Treace Medical class action, go to call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff. Follow us for updates on LinkedIn: or on Twitter: or on Facebook: Attorney Advertising. Prior results do not guarantee a similar outcome. ------------------------------- Contact Information: Laurence Rosen, Esq. Phillip Kim, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 40th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827 [email protected] To view the source version of this press release, please visit
Associated Press
12 hours ago
- Associated Press
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Avis Budget Group, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action
New York, New York--(Newsfile Corp. - June 7, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Avis Budget Group, Inc. (NASDAQ: CAR) between February 16, 2024 and February 10, 2025, both dates inclusive (the 'Class Period'), of the important June 24, 2025 lead plaintiff deadline. SO WHAT: If you purchased Avis Budget securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO DO NEXT: To join the Avis Budget class action, go to or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than June 24, 2025. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers. DETAILS OF THE CASE: According to the lawsuit, during the Class Period, defendants made false and/or misleading statements and/or failed to disclose that: (1) Avis Budget crafted and implemented a plan to significantly accelerate its fleet rotation in the fourth quarter of 2024; (2) the foregoing acceleration shortened the useful life of the majority of Avis Budget's vehicles in the Americas segment, thereby reducing their recoverable value; (3) as a result, Avis Budget would be forced to recognize billions of dollars in impairment charges and incur substantial losses; (4) all the foregoing was likely to, and did, have a significant negative impact on Avis Budget's financial results; (5) accordingly, Avis Budget's financial and/or business prospects were overstated; and (6) as a result, defendants' public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages. To join the Avis Budget class action, go to call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff. Follow us for updates on LinkedIn: or on Twitter: or on Facebook: Attorney Advertising. Prior results do not guarantee a similar outcome. ------------------------------- Contact Information: Laurence Rosen, Esq. Phillip Kim, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 40th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827 [email protected] To view the source version of this press release, please visit
Yahoo
19 hours ago
- Yahoo
Judge approves landmark college sports settlement
The corrupt system of denying payment to college athletes has officially ended. On Friday, Judge Claudia Wilken approved the settlement of multiple antitrust class-action lawsuits that challenged the longstanding refusal of the NCAA and its members to compensate athletes. Advertisement The deal includes $2.8 billion in payments to players over the past 10 years along with payments to players moving forward. This hardly ends the chaos currently consuming college sports. The major conferences have launched the College Sports Commission (which is different from the presidential commission that was under consideration for like a week) to regulate NIL collectives that have in many instances become pay-for-play programs. Here's the problem. Any collective action by independent businesses that restrict the earning capacity of the athletes potentially creates a fresh antitrust problem. Friday's settlement resolves (in theory) the manner in which the schools will directly compensate players. The NIL issue is separate. Advertisement And it should be open season, thanks to the American system of free enterprise. That's why the colleges want the federal government to throw them a lifeline with legislation that would include an antitrust exemption. The only truly effective solution would come from creating a nationwide union and negotiating rules regarding key issues like compensation limits and transfer rights. With that, however, the players would have the ability to secure protections against, for instance, unlimited padded practices and a year-round schedule of intense workouts that leave the players with very little time to themselves — especially relative to pro athletes. So the settlemen isn't the end. It's more like the end of the beginning, with plenty more work to be done.
